Cell-surface
receptors that link to heterotrimeric GTP-binding proteins (G proteins)
represent the most numerous transmembrane signal transduction pathways.
Indeed, membrane-bound G-protein-coupled receptors (GPCRs) are one
of the largest superfamilies in the human genome, comprising approximately
3% of human genes. These G protein-coupled receptors (GPCR) transduce
signals by coupling to G proteins that regulate an array of effector
molecules. Adenylyl cyclase is one such effector enzyme.
Adenylyl cyclase synthesizes the second messenger cyclic
adenosine 3’,5’ monophosphate (cAMP) from ATP. cAMP, via
its activation of PKA, initiates both rapid actions, such as regulation
of ion channels, and carbohydrate, protein and lipid metabolism,
as well as more delayed effects, such as changes in gene expression,
cell growth and proliferation. Adenylyl cyclase exists in nine different
isoforms that have different regulatory properties and, as we have
recently found, different localization in the plasma membrane.
Click
the Research link to learn more about
our studies of GPCR-adenylyl cyclase signaling.
An NIH-supported postdoctoral training position in the area of smooth muscle pharmacology is available in the Ostrom laboratory. Start date and salary are negotiable. Contact Dr. Ostrom for more information.
Are you an undergraduate interested in a career in biomedical research? Click for information on our Summer Undergraduate Research Fellowship.
Links to recent media covereage of Ostrom Lab research:
Memphis Business Journal
The Daily News
|